# The Efemoral Vascular Scaffold System (EVSS) for the Treatment of Patients With Symptomatic Peripheral Vascular Disease From Stenosis or Occlusion of the Femoropopliteal Artery

Study · id `cardio:ct-nct04584632` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04584632](<https://clinicaltrials.gov/study/NCT04584632>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT04584632

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 100 participants.

## Technical summary

Registry record NCT04584632. Allocation not applicable; no masking; primary purpose treatment. Start 2020-09-22 (actual); primary completion 2028-03 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 100 participants (planned count; ClinicalTrials.gov record NCT04584632, source copy `cardio:ctgov-nct04584632-2026-03-25`, retrieved 2026-10-31)
- Started: 2020-09-22 (actual) (ClinicalTrials.gov record NCT04584632, source copy `cardio:ctgov-nct04584632-2026-03-25`, retrieved 2026-10-31)
- Primary completion: 2028-03 (anticipated) (ClinicalTrials.gov record NCT04584632, source copy `cardio:ctgov-nct04584632-2026-03-25`, retrieved 2026-10-31)
- Completion: 2030-03 (anticipated) (ClinicalTrials.gov record NCT04584632, source copy `cardio:ctgov-nct04584632-2026-03-25`, retrieved 2026-10-31)
- Countries: Australia; New Zealand (ClinicalTrials.gov record NCT04584632, source copy `cardio:ctgov-nct04584632-2026-03-25`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04584632-2026-03-25`, retrieved 2026-10-31)

## The registry's words

- Brief title: The Efemoral Vascular Scaffold System (EVSS) for the Treatment of Patients With Symptomatic Peripheral Vascular Disease From Stenosis or Occlusion of the Femoropopliteal Artery
- Acronym: Efemoral I
- Condition: Peripheral Arterial Disease
- Condition: Vascular Diseases
- Condition: Stenosis
- Condition: Femoropopliteal Stenosis
- Intervention (Device): Efemoral Vascular Scaffold System (EVSS)
- Lead sponsor: Efemoral Medical, Inc.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Peripheral artery disease (`cardio:peripheral-artery-disease`)

## Provenance

Content hash: b3b751d871d1ddd819a13e7f0d35dd063c09b89a6c0cb0cb335a6b41ab2110d3
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
